Skye Bioscience, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Equity (Detail Textuals)

Equity (Detail Textuals)	1 Months Ended								3 Months Ended				6 Months Ended
Equity (Detail Textuals)	Jun. 30, 2015 USD ($) $ / shares shares	May. 31, 2015 shares	Apr. 30, 2015 USD ($) $ / shares shares	Mar. 31, 2015 $ / shares shares	Jan. 31, 2015 USD ($) $ / shares shares	Oct. 31, 2014 Investor shares	Aug. 31, 2014 USD ($) $ / shares shares	Jul. 17, 2012 USD ($) Advisor $ / shares shares	Jun. 30, 2015 USD ($) $ / shares shares	Mar. 31, 2015 USD ($) $ / shares shares	Dec. 31, 2014 USD ($) $ / shares shares	Jun. 30, 2014 USD ($) shares	Jun. 30, 2015 USD ($) $ / shares shares	Jun. 30, 2014 USD ($) shares
Equity [Line Items]
Number of shares called by warrants \| shares			100,000	90,000						90,000
Warrant exercise price (in dollars per share) \| $ / shares	$ 2.50		$ 5.00	$ 2.50					$ 2.50	$ 2.50			$ 2.50
Term of warrant			10 years	5 years
Value of common stock called by warrants	$ 67,950								$ 67,950				$ 67,950
Amortization of warrant service cost													$ 46,810
Number of shares issued for services \| shares				24,000		1,110,000
Fair market value of common stock issued recorded as prepaid expense										$ 168,000
Number of shares issued to group of private investors \| shares					241,663
Value of shares issued to group of private investors					$ 724,989
Par value of common stock issued (in dollars per share) \| $ / shares	$ 0.001			$ 0.001	$ 0.001				$ 0.001	$ 0.001	$ 0.001		$ 0.001
Number of individual investor \| Investor						18
General and administrative									$ 1,313,170		$ 466,200	$ 142,920	$ 2,185,795	$ 173,021
Preferred stock, shares authorized \| shares	20,000,000								20,000,000		20,000,000		20,000,000
Preferred stock, par value (in dollars per share) \| $ / shares	$ 0.001								$ 0.001		$ 0.001		$ 0.001
Series A preferred stock
Equity [Line Items]
Number of shares issued to group of private investors \| shares			250,000
Preferred stock, par value (in dollars per share) \| $ / shares			$ 0.001
Minimum equity financing under down-round protection feature			$ 1,000,000
Maximum common stock issuance price per share (in dollars per share) \| $ / shares			$ 2.50
Down round provisions expiration terms			earlier of (i) a subsequent equity financing of at least $1,000,000 or (ii) October 1, 2015.
General and administrative expense
Equity [Line Items]
Value of common stock called by warrants			$ 326,000
Amortization of cost of service													$ 71,800
Founders and Board member
Equity [Line Items]
Number of shares issued for services \| shares								7,770,000
Value of shares exchanged for services								$ 1,000
Warrants
Equity [Line Items]
Number of shares called by warrants \| shares	10,000		6,000				2,200,000	3,000,000	10,000				10,000
Warrant exercise price (in dollars per share) \| $ / shares	$ 5.00		$ 2.50					$ 1.00	$ 5.00				$ 5.00
Term of warrant	5 years		5 years
Number of advisors \| Advisor								2
Value of common stock called by warrants	$ 14,700		$ 10,000				$ 1,100,000		$ 14,700				$ 14,700
Number of shares issued to group of private investors \| shares			50,000
Value of warrants issued			$ 625,000
Warrants \| Series A preferred stock
Equity [Line Items]
Warrant exercise price (in dollars per share) \| $ / shares			$ 5.00
Number of shares issued to group of private investors \| shares		150,000
Warrants \| Stock Purchase Agreement June 2014
Equity [Line Items]
Number of shares called by warrants \| shares	450,000			450,000			550,000		450,000	450,000		1,800,000	450,000	1,800,000
Warrant exercise price (in dollars per share) \| $ / shares	$ 1.00			$ 1.00			$ 1.00		$ 1.00	$ 1.00			$ 1.00
Value of common stock called by warrants												$ 900,000		$ 900,000
Value of warrants issued							$ 104,500						$ 85,500